Regenerative Power of Stem Cells and Exosomes
MVHCO's providerrs products are distributed for analytical testing, research purposes, and/or use with FDA-approved Investigational New Drug (IND) applications, or other Institutional Review Board (IRB) approved protocols. Clinical use with patients requires full disclosure and signed consent.
The Evolution of Medicine
We are currently transitioning into the third epoch of medical evolution:
First Period: Relied on limited anthropological and scientific knowledge; often characterized as a brutal time.
Contemporary Period: Skills have advanced significantly, yet still rely heavily on invasive and scholastic methods.
Third Epoch (Self-Regeneration): The body contains the innate "know-how" to build, repair, and regenerate all tissues.
While developing in utero, the body possesses virtually unlimited regenerative capabilities, a capacity that begins to diminish immediately after birth. MVHCO harnesses perinatal products—specifically A-Matrix™ and UCB-Alo™—to provide a breakthrough in Stem Cell and Exosome therapeutics.
The Mechanism of Aging
Aging is an evolutionary conserved mechanism designed to "time out" individuals to free up resources for new generations. Most common medical ailments, including inflammation and degeneration, are directly related to this process.
The Supply and Demand Crisis
Cellular Loss: The living body loses an average of 300 million cells every minute.
The Replacement Gap: While young, tissue-specific adult stem cells keep up with this demand.
Telomere Shortening: Each time a stem cell divides, its telomeres shorten; once they reach a critical length, the cell can no longer replicate and dies.
Endogenous Depletion: Biological aging is essentially the depletion of these endogenous stem cells, leading to thinning skin, fading eyesight, and slower tissue repair.
Loss of Regenerative Capacity
As defined by Dr. Arnold Caplan, the "father of MSCs," there is a massive decline in Mesenchymal Stem Cells (MSCs) within bone marrow as we age:
Age Group
Ratio of MSCs to Bone Marrow Cells
Newborn 1 in 10,000
Teenager 1 in 100,000 (90% decrease)
30 Years 1 in 250,000
50 Years 1 in 400,000 (only 2.5% of newborn capacity)
60+ Years 1 in 2,000,000